Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating cardio-cerebro vascular disease and preparing method thereof

A technology for cardiovascular and cerebrovascular diseases and medicines, which is applied in cardiovascular system diseases, drug combinations, pharmaceutical formulas, etc., can solve the problems of toxic side effects, morbidity, high disability rate, slow clinical application effect, etc., and achieve relief Symptoms, Enhanced Effects

Inactive Publication Date: 2004-06-30
王德茂
View PDF0 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0002] Cardiovascular and cerebrovascular diseases are the most common frequently-occurring diseases that seriously threaten human health, and their incidence, prevalence, and disability rates are high. According to the report of the World Health Organization, the mortality rate of cardiovascular and cerebrovascular diseases ranks first in the world. Therefore, medical experts and scholars from all over the world are researching high-efficiency and low-toxicity drugs for the prevention and treatment of cardiovascular and cerebrovascular diseases from different angles and fields. Ester compounds, beta receptor blockers and calcium antagonists, but these western medicines can only temporarily eliminate symptoms (cure the symptoms), can not cure the cause of the disease (cure the root cause), and have certain toxic and side effects, while traditional Chinese medicines in my country treat cardiovascular and cerebrovascular Chinese patent medicines for diseases such as Guipi Decoction (pill), Dahuoluodan, Huitian Zaizao Pill, Naoxuekang and Ginkgo Leaf Oral Liquid, etc., have not received good curative effect due to slow clinical application, especially for traditional Chinese medicine. The clinically described "heart paralysis" refers to the myocardial infarction, myocardial ischemia and "chest paralysis" described in modern medicine, which are called coronary heart disease, as well as atherosclerosis and cerebral infarction. caused by the diseases brought about, and there is even a lack of curative symptomatic drugs

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicine for treating cardio-cerebro vascular disease and preparing method thereof
  • Medicine for treating cardio-cerebro vascular disease and preparing method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0012] The medicine and the preparation method of the prescription of the present invention form an overall mechanism for regulating the qi and blood of the "five viscera and six fu-organs" by consolidating the root and cultivating the source, consolidating the kidney qi, promoting the lung qi, invigorating the spleen and nourishing the liver, and aiming at "chest obstruction". Deficiency in origin, excess in superficiality, and both deficiency and excess are solid characteristics, and a kind of medicine for treating cardiovascular and cerebrovascular diseases with quick onset, stable function and no side effects is developed. In the prescription, astragalus, codonopsis, and sand ginseng are used to invigorate qi, activate blood, nourish yin and nourish qi to improve blood flow and improve microcirculation. Saffron promotes blood circulation, removes blood stasis, generates new blood vessels, Sanqi removes blood stasis, relieves coronary vasospasm, increases coronary blood flow...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to a Chinese medicine oral preparation for curing cardio-cerebral vascular diseases, such as myocardial ischemia, myocardiac infarction and cerebral infarction, its effectual rate is above 75% and total effective rate is 96.6%. Said oral preparation is made up by using 20 Chinese medicinal materials of astragatus root, pilose asiabell root, adenophora / glehnia root, schisandra berry, lycium berry, cuscuta seed, poria and other. Said invention also provides its preparation method.

Description

technical field [0001] The invention is a compound traditional Chinese medicine, specifically a traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases and a preparation method thereof. Background technique [0002] Cardiovascular and cerebrovascular diseases are the most common frequently-occurring diseases that seriously threaten human health, and their incidence, prevalence, and disability rates are high. According to the report of the World Health Organization, the mortality rate of cardiovascular and cerebrovascular diseases ranks first in the world. Therefore, medical experts and scholars from all over the world are researching high-efficiency and low-toxicity drugs for the prevention and treatment of cardiovascular and cerebrovascular diseases from different angles and fields. Ester compounds, beta receptor blockers and calcium antagonists, but these western medicines can only temporarily eliminate symptoms (cure the symptoms), can not cure...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61P9/10
Inventor 王德茂
Owner 王德茂
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com